Version control of pathway models using XML patches by Saffrey, P. & Orton, R.
 
 
 
 
 
 
 
Saffrey, P., and Orton, R. (2009) Version control of pathway models 
using XML patches. BMC Systems Biology, 3 (34). ISSN 1752-0509 
 
http://eprints.gla.ac.uk/59697 
 
Deposited on: 03 February 2012 
 
 
Enlighten – Research publications by members of the University of Glasgow 
http://eprints.gla.ac.uk 
BioMed CentralBMC Systems Biology
ssOpen AcceMethodology article
Version control of pathway models using XML patches
Peter Saffrey* and Richard Orton
Address: Department of Computing Science, University of Glasgow, Glasgow, G12 8QQ, UK
Email: Peter Saffrey* - pzs@dcs.gla.ac.uk; Richard Orton - rorton@dcs.gla.ac.uk
* Corresponding author    
Abstract
Background: Computational modelling has become an important tool in understanding biological
systems such as signalling pathways. With an increase in size complexity of models comes a need
for techniques to manage model versions and their relationship to one another. Model version
control for pathway models shares some of the features of software version control but has a
number of differences that warrant a specific solution.
Results: We present a model version control method, along with a prototype implementation,
based on XML patches. We show its application to the EGF/RAS/RAF pathway.
Conclusion: Our method allows quick and convenient storage of a wide range of model variations
and enables a thorough explanation of these variations. Trying to produce these results without
such methods results in slow and cumbersome development that is prone to frustration and human
error.
Background
The use of computational modelling is becoming wide-
spread within the biological community. Models are
applied to a diverse array of problems and are now a
standard analysis technique used both in academia and
industry.
Although modelling is now widely used, the methodol-
ogy that supports modelling remains underdeveloped. In
particular, a model will often develop and change over
time, giving rise to many model versions but there is very
little published work on model version control. Some
aspects of model version control are similar to the estab-
lished field of software version control. However, there
are a number of significant differences that mean a sepa-
rate treatment is needed.
Many of the differences between software and model ver-
sion control have at their core a difference in aims. The
aim of a piece of software is to address a specific problem,
described by its requirements. The aim of a model is the
far more vague goal of understanding a biological system,
sometimes expressed as specific questions (such as "does
this set of reactions provoke a sustained or transient
response?"), sometimes as how behaviour might change
under different conditions and sometimes as a more gen-
eral exploration of system properties.
This contrast between the convergent aims of a software
project and the more divergent aims of a modelling project
make the version control needs fundamentally different.
These differences include the need to manage combinations
of model versions, giving rise to a much greater branching
factor. There is also a need to maintain a larger number of
alternatives that are still relevant at any given time.
To address these differences, we have devised a flexible
patch-based version control system that differs from exist-
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a modification to an existing model: an addition, deletion
or replacement of existing pieces. Patches can be applied
in combination while retaining the original model struc-
ture. This allows later patches to work on the original sys-
tem, or on a configuration created with existing patches.
This flexible approach allows a modeller to rapidly
explore a wide variety of model configurations without
overwriting any previous ideas. We have applied the sys-
tem to models expressed in SBML [1], to take advantage of
the broad support for the language and the regular struc-
ture provided by XML documents. Working with XML
models also means that our system could be easily
extended to support other XML modelling tools, such as
CellML [2].
In this paper we present details of our patch based system
along with a prototype implementation. Our method is
generic enough to apply to many areas of computational
modelling. However, as a motivating example we have
developed our methods in conjunction with a specific sys-
tem: the EGF pathway. We illustrate the method with ref-
erence to the EGF pathway in a variety of versions.
Software and Modelling Version Control
Software Version Control
Software version control is a mature and established disci-
pline of software engineering. A characteristic progression
of versions is shown in the left hand diagram of figure 1.
The main features of this progression are:
• Versions proceed in a roughly linear fashion working
towards a single set of requirements. Requirements
may change but at any one time there is only one set.
• Each new version represents an improvement over
(and usually replacement of) previous versions.
• Branching does occur, but features from different
branches are usually folded back into an overall 'best'
version.
Software version control tools, such as CVS [3], SVN [4]
and Git [5], are designed to support these characteristics of
software development with features including distributed
access and the ability to fork new versions and merge
these together.
Model Version Control
Although a pathway model is often a software artifact,
there is little published material on using version control
systems to track model version changes. There are a
number of obvious distinctions between the progression
of a pathway model and the progression of a software
project. A characteristic progression of versions is shown
in the right hand diagram of figure 1. The main features of
this progression are:
• A model starts as a simple base and then a number
of possible extensions to the pathway are suggested,
each of which are largely independent of each other.
Software and modelling version developmentFigure 1
Software and modelling version development. Software development (on the left) tends to have a linear progression, 
with the aim of a single 'best' outcome. By contrast, model development (right) is a more divergent and exploratory task, 
encompassing various hypotheses concerning which parts of a pathway are relevant under different conditions.
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which is only present under certain conditions. An
extension may also represent an investigation into
whether a particular extra section of pathway is impor-
tant or not. Each new version may represent the same
part of a pathway under a different hypothesis, but is
not necessarily an improvement or replacement for
another hypothesis.
• Branching generates a combinatoric effect; each new
extension can be applied to all the previous combina-
tion of extensions.
It may be possible to manage such a progression using a
software version control system, but it would not be a nat-
ural fit. Each combination of extensions would be
assigned a version number and a user would have to con-
tinually track back and forth along this timeline to locate
the setup they were interested in. Applying a new exten-
sion to an existing set of combinations would require a
good deal of extra work.
XML diff and patch
A variety of systems already exist to record differences in
XML files and allow these changes to be duplicated. A
good review of these technologies can be found in [6].
Several algorithms [7,8] have been developed to recognise
XML changes (known as a "diff") and record these
changes. There are implementations of these techniques
from IBM [9] and others [10].
Simulink
Simulink is the modelling component of the mathemati-
cal toolkit Matlab [11]. Simulink allows model design
based on the connection of components and provides
integration with version control systems, so that each
component can have its own version history.
Simulink is a flexible and powerful system, but the version
control mechanisms are still based on traditional software
version control; the patch-based combinatoric modifica-
tion of models we propose is not supported.
Results
Case Study: EGF pathway
To demonstrate our system we have tested it on a suite of
models based on the EGFR/MAPK system. The Mitogen
Activated Protein Kinase (MAPK) pathway is at the heart
of a molecular signalling network that governs the
growth, proliferation, differentiation and survival of
many, if not all, cell types [12-14]. It is deregulated in var-
ious diseases ranging from cancer to immunological,
inflammatory and degenerative syndromes, and thus rep-
resents an important drug target. Perhaps the most impor-
tant and intensively studied MAPK pathway is the
Extracellular-signal Regulated Kinase (ERK) pathway,
which is typically initiated by the activation (via ligand
binding) of cell surface receptors, such as the Epidermal
Growth Factor (EGF) or Nerve Growth Factor (NGF)
receptors (Figure 2). In essence, there are two distinct
pathways leading from activated receptors to ERK activa-
tion, the Ras pathway which proceeds via SOS-Ras-Raf1
and the Rap1 pathway which proceeds via C3G-Rap1-
bRaf. Activated ERK has numerous targets in both the
cytoplasm and nucleus, including numerous transcription
factors, and can therefore directly effect gene expression
and influence cellular outcome. In addition, ERK is able to
phosphorylate SOS (via Rsk) thus forming a negative
feedback loop within the pathway [15,16].
One of the most common cell lines used to investigate
ERK signalling from growth factor receptors is the PC12
(rat pheochromocytoma) cell line. In PC12 cells, EGF
stimulates a rapid but transient activation of ERK, peaking
at 5 mins and returning to basal levels at 30 mins, leading
to cellular proliferation [17,18]. In contrast, Nerve
Growth Factor stimulates a sustained activation of ERK
leading to the neuronal differentiation of PC12 cells
[17,18]. There is now compelling evidence that the dura-
tion of the ERK signal governs whether PC12 cells prolif-
erate or withdraw from the cell cycle and differentiate into
a neuronal phenotype [17,18]. Although the PC12 system
has been well studied, it is still unclear how different ERK
signal dynamics can be robustly controlled by different
upstream receptors. Furthermore, there is a currently
some debate as to which of the two pathways (Ras and
Rap1) is utilised by the different receptors to activate ERK
and relay their signal. Some groups have reported that
both EGF and NGF can only use the Ras pathway [19,20],
whilst others report that NGF but not EGF can also use the
Rap1 pathway [21], whilst another group has reported
that both NGF and EGF can use both the Ras and Rap1
pathways [18]. Over recent years the computational mod-
elling of biological systems has become increasingly valu-
able and there are now a wide variety of models of the ERK
pathway available which have led to some novel insights
and interesting predictions as to how this system func-
tions [22]. However, none of these studies utilised a mod-
ular or patch approach in their model design and analysis.
This is unfortunate, given that the ERK pathway can be uti-
lised by different receptors with different properties, and
that there are different pathways that can be used by
receptors to activate ERK. A patch system would enable
one to rapidly build different versions of a receptor system
composed of different pathways and feedback loops, as
well as enabling the rapid application of the system to dif-
ferent receptors with different properties. This would ena-
ble one to rapidly investigate which version best reflects
the available biological data, which pathways (or patches)
are critical for relaying the signal, and also enable the easyPage 3 of 13
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potential of our patch approach, we took the computa-
tional model of the ERK pathway developed by Brown et
al. (2004) [23] and split it into a number of distinct
patches (Figure 2). We investigated the debate surround-
ing the use of the Ras and Rap1 pathways in NGF receptor
signalling by utilising the patch approach to generate and
compare three different models of the receptor system. All
three models included the core ERK patch (blue) and then
the following model specific patches:
1. Ras Model: This model included the Ras pathway
patch (green) and the SOS feedback patch (orange).
2. Rap1 Model: This model included the Rap1 path-
way patch (red).
Schematic of the receptor activated ERK pathwayFigure 2
Schematic of the receptor activated ERK pathway. This schematic has been split into a number of distinct sections or 
patches which are: (1) Blue: the core patch consisting of ligand/receptor binding and the core ERK pathway; (2) Green: the Ras 
pathway which links bound receptors to ERK activation; (3) Red: the Rap1 pathway which links bound receptors to ERK activa-
tion; (4) Orange: the negative feedback loop from ERK to SOS via Rsk; and (5) Purple; the Akt pathway. In the schematic, links 
which end in arrows represent activating reactions whilst links which end in diamonds represent deactivating reactions.Page 4 of 13
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pathway patch (green) and the SOS feedback patch
(orange), as well as the Rap1 pathway patch (red).
We first created the Ras model by using our Patch Tool to
select our core ERK patch (blue) along with the Ras
(green), and SOS feedback (orange) patches and subse-
quently launched and simulated the model in Copasi. We
then used our Patch Tool to create the Rap1 model by
deselecting the Ras and SOS feedback patches and select-
ing the Rap1 patch instead, then re-launched Copasi with
the new model whilst maintaining our original simula-
tion and plot settings. The Ras & Rap1 model was then cre-
ated and simulated in a similar fashion. As can be seen in
Figure 3, the Ras model produces a transient active ERK
response whereas the other two models, which both
include the Rap1 pathway, produce a sustained active ERK
response. As NGF is well known to stimulate the sustained
activation of ERK in PC12 cells, our simulation results
suggest that the NGF receptor must signal via the Rap1
pathway in order to achieve this. Overall, this example
illustrates the potential of our patch approach as it ena-
bles one to rapidly create different versions of a system to
investigate the role that entire pathways play in the
dynamics of signalling and investigate which one best
reflects the available biological data. To accomplish this
manually can often be a tedious affair where reactions and
species are manually deleted to create new model files
which are individually named and saved. However, if an
error is found or an update/expansion is required, all of
the saved files containing the different model versions
may well need to be changed, whereas with our approach
only the corresponding patch will need to be changed
once. The close integration of our Patch Tool with the sim-
ulation tool Copasi is also extremely useful as once
patches have been selected the model can be rapidly sim-
ulated and analysed, especially as both simulation and
plot options are maintained as models are updated.
The patch approach can also be used to create dependent
patches which are patches that can only be introduced
into a model when a specific patch is already present. This
is a useful feature when one wants to apply changes to an
existing patch, such as kinetic parameter changes or spe-
cies knockouts. In biological terms, such species knock-
outs could represent the available RNAi's to knockout
proteins by knocking down gene expression, enabling one
to investigate which proteins play the biggest role in trans-
ducing the signal. One interesting area of current research
is focussed on how the EGF receptor system can be manip-
ulated to give a sustained rather than a transient response
[24,25]. Using our Patch Tool to investigate this, we cre-
ated two species knockout patches which knockout Rsk
and PI3K, respectively. As can be seen in Figure 4, knock-
ing out PI3K has little effect on the active ERK plot whilst
knocking out Rsk has a dramatic effect with the active ERK
signal switching for a transient to a sustained response.
Knocking out Rsk effectively knocks out the negative feed-
back loop from ERK to SOS, which suggests that this feed-
back loop is essential for signal termination. Whilst
knocking out PI3K effectively knocks out the whole Akt
pathway, as no other species can activate Akt, which sug-
gests that the Akt pathway plays little role in either signal
initiation or termination.
Our patch approach and tool can also be used to create
patches that are mutually exclusive which is a useful fea-
ture when investigating cancerous mutations. The ERK
pathway has long been associated with cancer as muta-
tions to various proteins in the pathway are well known to
result in the constitutive activation of ERK leading to
uncontrolled cell growth [26-28]. For example, one of the
most common Ras mutations is a glycine to valine muta-
tion at residue 12 (RasV12) which renders Ras insensitive
to inactivation by Ras-GAP and thus locked in the active
state [26]. To illustrate the potential of our patch
approach, we constructed a cancerous Ras pathway patch
containing a constitutively active Ras and made it mutu-
ally exclusive with the standard Ras pathway patch. As can
be seen in Figure 4, swapping the standard Ras pathway
patch for the cancerous Ras pathway patch results in the
active ERK signal switching from a normal transient
response to a constitutively active response. This example
illustrates the potential of the patch approach in investi-
gating the effects of diseases such as cancer where patches
representing normal and mutated/modified conditions
can be created. One can imagine a situation where patches
representing the different cancerous mutations have been
generated along with patches representing the most com-
mon drug treatments allowing one to test which drug/
combinations are the best treatments for each of the dif-
ferent forms of cancer. To illustrate this, we created a
parameter change patch to represent a hypothetical drug
capable of increasing the kcat value of PP2A by a factor of
10. This means that one can simply select the drug from
the list of parameter patches and then simulate the model
to analyse it effects. As can be seen in Figure 5, such a drug
appears to be an effective treatment against cancers caused
by RasV12.
Discussion
Future Work
Standardised Tools
For simplicity and convenience, our tool was based on an
in-house implementation of the xml-diff techniques. How-
ever, it would be good software engineering practise to base
our tool on an established XML technology such as [9].
Version Control and Source Code Management
In this paper, we are concerned specifically with version
control: how to allow a modeller to extend and change
their model and revert to previous versions if necessary.Page 5 of 13
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which provides a group of programmers with a means to
collaborate on a software project by managing the source
code, although most SCM systems include a version con-
trol facility. Our work could easily be extended to encom-
pass elements of source control management. The base
model and patches could be uploaded into a SCM system
such as SVN, which would allow users to upload new
patches, amend existing patches and access the entire set
of patches from a collaborative project. The difficulty with
such an approach is defining the granularity of a model
amendment. When a change is made to a model, should
this be change to the base model, to one of the existing
patches or an entirely new patch?
The view of the authors is that an XML patching system
should be seen as complementary to existing SCM
approaches. XML patches make hypothesis testing and
combinatorial model changes far easier to manage but are
not a replacement for disciplined use of an SCM in a col-
laborative environment.
Model Repositories
The issue of model granularity also arises when deciding
how to submit a patch-based model to a model repository,
such as Biomodels.net [29]. Many patch based models will
not have a complete amalgamated version since removal
patches may remove some of this amalgamated behaviour.
One possibility is to upload a number of patch combina-
Simulations of the NGF receptor systemFig re 3
Simulations of the NGF receptor system. This chart contains simulation traces from various NGF receptor system mod-
els. The x-axis represents time in minutes whilst the y-axis represents the concentration of active ERK in molecules/cell. The 
blue line represents the simulated level of active ERK from the original Brown NGF model with both the Ras and Rap1 path-
way patches, whilst the red line represents simulated active ERK with only the Rap1 pathway patch, and the green line repre-
sents simulated active ERK levels with only the Ras feedback patch. As can be seen, the Rap1 pathway patch is required to 
achieve a sustained ERK signal as the Ras pathway patch alone is only capable of producing a transient signal.Page 6 of 13
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tions for the model representing some more important
configurations. Whether this is feasible will depend on the
final number of important patch combinations.
Ideally, it should be possible to upload a base model and
set of patches to allow other database users the flexibility
to patch and use the model as intended. In this case, a
patch standard should be devised with a reference imple-
mentation to allow model databases to support patch
upload and application. This would be a more long-term
development for this work.
Model Provenance
It might also be useful to include further methodological
provisions to document model development and prove-
nance. The plots resulting from a model run should be
stored along with the configuration of patches used to gen-
erate those plots. These model reports should be stored in
a database for search and retrieval. This infrastructure
would leverage the patching approach to improve the effi-
ciency of model development, as described in [30,31].
However, we believe that the best way to drive further work
is to be motivated by ongoing projects. We are working with
members of the SIMAP (Simulation modelling of the MAP
kinase pathway) project at Glasgow to develop patching
tools specific to the modelling needs of that project to
develop the patching approach as it can be most useful to
active work.
Element Name Clashes
Our patch system relies on unique element identifiers to
make unambiguous references into each XML document. In
larger projects with many contributors, the patch system
should provide some further support to help avoid name
clashes.
As a first step, the patch-set should include a name-space
summary that shows what names are present in the model
and in which parts of the model, base or patches, each
name appears. The patch system should also allow anno-
tations to be added to this name-space to provide a more
detailed description of each name and how it differs from
Simulations of the EGF receptor systemFig re 4
Simulations of the EGF receptor system. This chart contains simulation traces from various EGF receptor system mod-
els. The x-axis represents time in minutes whilst the y-axis represents the concentration of active ERK in molecules/cell. The 
blue line represents the simulated level of active ERK from the original Brown model, whilst the red line represents simulated 
active ERK levels with a Rsk knockout, and the green line represents simulated active ERK levels with a P13K knockout. As can 
be seen, knocking out the PI3K has little effect on active ERK whilst knocking out Rsk has a dramatic effect with the signal 
switching from a transient to a sustained response.(page number not for citation purposes)
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Simulations of cancerous mutationFig re 5
Simulations of cancerous mutation. This chart contains simulation traces of the EGF receptor system model with and 
without a RasV12 cancerous mutation. The x-axis represents time in minutes whilst the y-axis represents the concentration of 
active ERK in molecules/cell. The blue line represents the simulated level of active ERK from the original Brown EGF model 
with the normal Ras pathway patch, whilst the red line represents simulated active ERK with a cancerous RasV12 pathway 
patch. As can seen, swapping the normal Ras patch for a cancerous patch results in the constitutive activation of ERK which 
would lead to uncontrolled cell growth. The green line represents the simulated level of active ERK with the cancerous RasV12 
patch and a hypothetical drug which increasing the catalytic activity of PP2A by a factor of 10. As can be seen, the drug is suc-
cessful at treating the cancer as it brings active ERK down to basal levels.
Table 1: Patch applications in pathway modelling
Patch feature Example application
Addition patch Adding a substrate or reaction
Deletion patch Removing a substrate or reaction
Replacement patch Changing a reaction rate
Addition patch file Adding a new pathway of reactions and substrates
Remove patch files A knockout of a substrate and its associated reactions
Replacement patch files Changing a set of reaction rates
Dependent patches A knockout applied to a particular pathway
BMC Systems Biology 2009, 3:34 http://www.biomedcentral.com/1752-0509/3/34similar names. New patches should refer to this name list
and warn where name clashes exist.
Ideally, the names used in a model should be based on a
controlled ontology, similar to the Gene Ontology [32].
This would reduce the possibility of ambiguity to a mini-
mum, make it clear what is referred to by each model ele-
ment and facilitate interoperability between models.
Other SBML Features
Our case study only addresses modifications to species,
reaction and parameter elements. However, alterations to
other SBML elements should be accommodated. For exam-
ple, introducing SBML events would be an addition patch
of the chosen events. Altering the triggers for these events
would be replacement amendments for those triggers.
In some cases, the introduction of these new elements
may constitute a broader structural change to the model,
which would require treatment outside of the patch sys-
tem (see below).
Structural Changes
The XML patching system works well where new concep-
tual features, such as pathway sections, are introduced and
removed from a system. However, it is not so appropriate
when a model undergos a large structural change.
For example, if an existing model is converted to use SBML
compartments, this would mean assigning all species to a
compartment, so an appropriate patch would represent the
entire model changing. In this case, it would be easier to
start again with a fresh model of the new structure.
Once a model is built around compartments, new patch
sets may be needed to represent common operations on
compartment models. These could still be based on the
addition, deletion and replacement amendments, but
these may need to be mixed in a single patch set. For
example, a species may be moved from one compartment
to another – a deletion and addition amendment in the
same patch set. This would necessitate dependency check-
ing to ensure that other patches do not attempt to delete
this species after it has been moved somewhere else.
Managing Other Model Types
CellML is similar in structure to SBML and the addition,
deletion and replacement patch approach should be
applicable here. New CellML components can be added
using addition patches or existing ones augmented or
reduced using addition and deletion patches. The compo-
nent framework of CellML might allow a broader applica-
tion of the patch approach. An addition could be used to
represent the insertion of a component and this same
patch may be used to insert this component into a variety
of base models. Some additional information may be
required to tailor the component interface to a variety of
models, but it may be possible to implement a compo-
nent approach to modelling in this way.
As with SBML, deeper changes may cause alterations
across several elements; these can be represented with a
combination of addition and deletion patches but may
require dependency checking not to break the application
of other patches. Again, as with SBML models, deep struc-
tural changes might be better represented with an entirely
new model.
The addition-deletion-replacement scheme might also
work effectively to manage a set of model versions in a
broader environment – a Matlab model, or one written in
C++ for example. These generic models can still be repre-
sented as a base and a set of changes, although the imple-
mentation of identifying and applying changes will need
to address the model representation.
Conclusion
We have presented a version management system for
pathway models. We have shown how using SBML docu-
ments can allow the application of separate model
amendments in combination by using an XML patch sys-
tem. We have also presented an implementation of these
ideas and their application in a case study.
Methods
XML Patching Implementation
Our XML patching implementation is based on the Fast
Match Edit Script method described in [7]. We have
implemented a simplified version of this algorithm to
make the system more lightweight and give us fine-
grained control over the way differences are detected and
recorded as patches.
Although the patch technology we describe here is
generic, we have developed the system specifically for use
with pathway models. During this section we will describe
how each concept applies to these models.
Patch generation
A patch represents a change or δ between a base system B
and a base system with a single amendment C: .
Patch generation is a function that takes as input a base and
a changed system and returns a patch δ that describes how
to alter the base system to look like the changed system.
There are three types of patch that can be identified during
patch generation: addition, deletion and replacement. In
each case, an xpath [33] expression is used to specify
B C→
dPage 9 of 13
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erences the id attributes used in SBML documents to make
sure the referenced position is unambiguous.
Some tools like Copasi produce models using anonymous
numbered id attributes such as 'id3'. To prevent name con-
flicts when new patches are created, we process models so
that each element take its name as the id. This method is
effective so long as the modeller does not use the same
name to model different species and is sufficient for a pro-
totype implementation. In larger modelling projects with
many contributors, or where a model is passed from one
modeller to another, the possibility of name clashes
increases. This will be discussed further in the Future Work.
In a deletion patch, the xpath specifies the XML node to
be removed. An addition patch specifies the XML node to
be added at the given xpath. A replacement patch specifies
the XML node which should be used as the replacement
for the node at the given xpath.
A replacement patch could also be represented by a dele-
tion and an addition, but dividing it into two patches
makes the function of the patch less clear and less effi-
cient. A replacement patch of the complete document
would constitute a δ between B and C but would again be
less clear and less efficient; the xmldiff algorithm builds
the smallest possible replacement patch, with the mini-
mum patch size being one complete XML element.
Model version control tool screenshotFigure 6
Model version control tool screenshot. This figure is a typical view of our version control tool in use. The top text box 
shows the base model to which the various patches can be applied. The left hand panel shows the pathways (addition patches) 
available. The central panel shows knockout (deletion patches). The right hand panel shows parameter sets (change patches). A 
text box at the bottom shows a Copasi file storing configuration settings for models (such as variables for plotting), which will 
be applied to Copasi on choosing the 'patch and simulate' button.Page 10 of 13
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be possible to use patches at this level of granularity.
However, element level addition and replacement patches
can contain complete well-formed XML to insert at this
point. To implement attribute additions and replace-
ments requires making a special case, since an attribute on
its own needs extra structure to become well formed XML.
Any attribute are still possible with element level patches
and can be implemented without augmenting the schema
to include special cases.
These patch operations are similar to the Delta Update
Language described in [6] but without the move operation.
Patch files
Individual addition, deletion and replacement amend-
ments can be grouped together into patch files. Each patch
file represents a number of amendments to transform a
base system into the base system with some collection of
changes. In theory, patch files could contain a mixture of
addition, deletion and replacment changes. However, this
raises the possibility that individual amendments contra-
dict each other: for example, a deletion may delete the
point at which an addition should occur. For simplicity, we
only allow each patch file to contain amendments of one
type. This gives rise to patch files that represent either a set
of additions, or a set of deletions, or a set of replacements.
In a pathway model, an addition patch file represents a
new part of the pathway, including new substrates and
their associated reactions. A deletion patch file represents
a knockout, where one or more substrates have been
removed from the system.
A replacement patch file represents altering the kinetics of
one or more reactions, providing a new set of parameters.
The change patch file contains one change amendment for
each parameter. Each amendment refers to the XPath for
that particular parameter and contains a complete XML ele-
ment representing that parameter, with the new value as
the "value" attribute. Collecting a set of parameters into a
single file and allowing a number of such sets is similar to
the concept of Parameter Run File presented in [30].
Patch dependencies
In some cases, it is desirable to impose dependencies on a
set of patches so that one patch can be applied only after
another. It is also possible for one patch to exclude the use
of another.
In a pathway model, a particular knockout will only make
sense in the presence of the targetted substrates and reac-
tions. A knockout patch can therefore depend on a new
pathway patch that introduces these substrates and reac-
tions to the base system.
A new pathway patch may exclude another if these represent
different conditions of the same pathway. For example, one
patch may represent the normal condition of this pathway
and another the cancerous condition; only one version of the
pathway should be applied for a particular configuration.
Patch Schema
An outline of the patch schema is as follows:
• Changes Top level element. Attributes: name of
patch.
- Description Textual itemize of patch.
- Dependency List A list of dependencies.
* Dependency Attributes: name of patch upon
which this patch depends
- Exclusion List A list of exclusions.
* Dependency Attributes: name of patch
which cannot be applied of this patch is
applied.
- Change List List of patches.
* Change Attributes: type (addition, deletion
or replacement); xpath to change location. If
this is an addition or replacement patch, the
elements beneath this node will be what
should be inserted at the xpath provided.
Summary: patches applied to pathway models
Table 1 provides examples of how the patch system might
apply in a pathway context.
Tool overview
To demonstrate the efficacy of our approach, we have
implemented a prototype and evaluated it on a case study
(see Case Study section). The tool was implemented in
Python using the pxdom XML library and Tkinter to pro-
vide a graphical user interface. Figure 6 shows a screenshot
of the tool in use.
Copasi Integration
Our tool operates on biological models expressed in
SBML. To obtain these models and to simulate models
after applying the patches, we have integrated our tool
with the popular SBML simulation tool Copasi [34].
Patches are generated from Copasi-generated SBML files
and Copasi can be automatically launched on a model
with the selected patches. We also allow Copasi configu-
ration information, such as variable plots, saved in a
Copasi file to be used for successive patched systems.Page 11 of 13
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A basic use-case for the tool is as follows:
Setup pathway patches
1. Using Copasi, build a 'base' model and export as
SBML, containing the fundamental elements of the
overall system. Import this base system into the patch
tool
2. Also using Copasi, build an extended model repre-
senting the base system along with an extra pathway.
Export this as SBML and import into the patch tool.
Add a name and description for this pathway.
3. Repeat step 2 for additional pathways. In each case,
build an SBML file that represents the base file with
the substrates and reactions of a new pathway added.
Setup knockouts and parameter sets
1. If desired, add one or more knockouts. Each knock-
out can apply to one or more pathways or to the base
system. The tool provides a dialog box to select the
substrates to be knocked out.
2. If desired, add one or more parameter sets. Parame-
ters sets can apply to one or more pathways or the base
system.
Choose patches to apply
1. Select the pathways, knockouts and parameter sets
for the desired model configuration. If a knockout or
parameter set depends on a pathway, this pathway
also must be selected.
2. Save the chosen model configuration to SBML or
automatically launch it in Copasi.
Availability and requirements
The software prototype described in this paper is availa-
ble.
Project Name XML patching tool.
Project Home Page The tool is available at http://
www.dcs.gla.ac.uk or see additional files 1. A README
file is included with the distribution. There is also a sam-
ple set of patches for testing to be found in http://
www.dcs.gla.ac.uk/~pzs/sample-patchset.tgz or see addi-
tional files 2.
Operating System The tool has been tested on Ubuntu
Linux 8.04 and Mac OS 10.4, but should work on other
platforms that support Python.
Programming Language Python.
Other requirements Python-xml libraries; pxdom; an
SBML compliant modelling tool such as Copasi.
License GNU GPL.
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